We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > orphan products

News List

As promised, Novartis eyes new method for funding ultrapricey next-gen drugs: FT fiercepharma
December 19, 2018
Novartis is weighing an insurance method often associated with natural disasters to help win coverage for its pricey next-generation cell and gene therapies.
FDA Awards 12 Grants to Fund New Clinical Trials americanpharmaceuticalreview
September 26, 2018
The U.S. Food and Drug Administration (FDA) has awarded 12 new clinical trial research grants totaling more than $18 million over the next four years to enhance the development of medical products for patients with rare diseases.
Protalex Awarded Grant from FDA Office of Orphan Products Development for PRTX-100 americanpharmaceuticalreview
August 21, 2017
Protalex announced the U.S. Food and Drug Administration (FDA) Office of Orphan Products Development (OOPD) has awarded the Company a $403,000 grant to support future clinical development activity of PRTX-100 as a treatment for Immune Thrombocytopenia (IT